Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPM3480392 for Moderate to Severe Pain After Orthopedic Surgery
NCT06467409Phase 2Recruiting
- Sponsor
- Luye Pharma Group
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LPM3480392 in postoperative pain, sponsored by Luye Pharma Group. Started Jan 2024; status: recruiting.
02
Drugs
LPM3480392
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06467409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06467409.